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RNA sequences are expected to be identical to their
corresponding DNA sequences. Here, we found all
12 types of RNA-DNA sequence differences (RDDs)
in nascent RNA. Our results show that RDDs begin
to occur in RNA chains55 nt from the RNA polymer-
ase II (Pol II) active site. These RDDs occur so soon
after transcription that they are incompatible with
known deaminase-mediated RNA-editing mecha-
nisms. Moreover, the 55 nt delay in appearance indi-
cates that they do not arise during RNA synthesis by
Pol II or as a direct consequence of modified base
incorporation. Preliminary data suggest that RDD
and R-loop formations may be coupled. These find-
ings identify sequence substitution as an early step
in cotranscriptional RNA processing.INTRODUCTION
DNA carries instructions for cellular proteins by providing the
code that is transcribed into mRNA that in turn is translated
into proteins. It is generally assumed that DNA sequences are
copied faithfully into RNA. However, there are exceptions to
this one-to-one relationship between RNA and its corresponding
DNA sequences. The first example of a transcript sequence that
is not encoded by DNA was reported by Benne et al. (1986), who
showed that the coxII mRNA in trypanosome has four nucleo-
tides that are not encoded in the DNA. They then coined the
term ‘‘RNA editing’’ for this ‘‘novel mechanism of gene expres-
sion’’ (Benne et al., 1986). Other examples of RNA editing were
soon discovered in organisms ranging from plants to metazoans906 Cell Reports 6, 906–915, March 13, 2014 ª2014 The Authors(Cattaneo et al., 1989; Driscoll et al., 1989; Gott et al., 1993;
Gualberto et al., 1989). In humans, RNA editing occurs in pro-
cesses mediated by the ADAR (adenosine deaminases that act
on RNA) (Bass and Weintraub, 1988) and APOBEC (apolipopro-
tein B mRNA editing enzymes) (Chen et al., 1987; Powell et al.,
1987) families of proteins. This leads to A-to-G (adenosine to
inosine, which is then recognized as guanosine) and C-to-U
(cytidine to uridine) changes. Recent advances in sequencing
technologies have enabled deep sequencing of DNA and RNA,
allowing other investigators (Alon et al., 2012; Bar-Yaacov
et al., 2013; Chen, 2013; Chen et al., 2012; Ju et al., 2011; Lagar-
rigue et al., 2013; Peng et al., 2012; Silberberg et al., 2012; Vesely
et al., 2012) and us (Li et al., 2011) to uncover more RNA-DNA
sequence differences (RDDs) than canonical RNA-editing
events. In different human cells and using various sequencing
and analytical methods, we and others have found all 12 types
of RDDs.
Although the mechanisms that mediate A-to-G and C-to-U
editing in humans are known, we do not know how the other
types of RDDs arise. For instance, A-to-C transversions are not
likely to be mediated by the ADAR and APOBEC families of
deaminases. In order to distinguish among the different types
of underlying mechanisms, in this project we sought to deter-
mine when RDDs arise. For this purpose, we compared nascent
RNA sequences with their corresponding DNA sequences. The
results show that all 12 types of RDDs occurred early during tran-
scription. We found RDDs in transcripts beginning at 55 bases
from the active site or35 bases beyond the exit channel of RNA
polymerase II (Pol II). This demonstrates that the RDD events
occur by a mechanism that is distinct from altered base selec-
tivity during catalysis of chain elongation by Pol II. Nonetheless,
the RNA processing events that mediate RDDs are closely
coupled temporally and spatially to transcription in human cells.
Given that RDDs emerge so soon after transcription, we studied
Figure 1. GRO-Seq and PRO-Seq Analysis
(A) Schematic of GRO-seq and PRO-seq.
(B) Comparison betweenGRO-seq and PRO-seq. Sense and antisense transcripts associated with TSSs are shown for GRO-seq and PRO-seq samples. A slight
shift of the PRO-seq promoter-proximal peak downstream relative to theGRO-seq peak is seen because the PRO-seq reads that were <35 nt were notmapped in
the analysis, and because GRO-seq maps 50 ends and PRO-seq maps 30 ends of nascent RNAs.
(C) mRNA-seq, chromatin-bound nascent RNA-seq, GRO-seq, and PRO-seq results for two representative genes, UVRAG and CAPZB. For genes with proximal
Pol II pausing, such as UVRAG, there are more reads mapping to the 50 ends of genes in both GRO-seq and PRO-seq samples. The schematic gene structure is
aligned to mRNA-seq results, with boxes representing exons, lines representing introns, and arrowheads showing the direction of transcription. Coverage is
calculated using a bin size of 1,500 bp and 600 bp, respectively.
(D) Scatterplot of gene expression levels fromGRO-seq andmRNA-seq (FPKM > 0.1). Results fromGM12750 (shown) and GM12004 are similar (r = 0.45 for both
samples). The heatmap indicates the frequency of different expression levels.cells from a patient with an autosomal-dominant form of juvenile
amyotrophic lateral sclerosis (ALS) due to a mutation in the sen-
ataxin gene, and found suggestive evidence that RDD formation
may be coupled to R loops.
RESULTS
Nascent RNA from GRO-Seq and PRO-Seq
To determine whether RDDs occur during or after transcription,
we sequenced nascent RNA using two global run-on sequencing
methods: GRO-seq (Core et al., 2008) and precision run-on
sequencing (PRO-seq; Figure 1A; Kwak et al., 2013). We ob-
tained 100 million 100 nt uniquely mapped GRO-seq reads
from B cells of two individuals. For one subject, we carried out
two independent PRO-seq experiments and obtained 60
million uniquely mapped reads in each experiment. Additionally,
we isolated and sequenced nascent RNA with an alternate
method (Wuarin and Schibler, 1994) for comparison (chro-
matin-bound RNA-seq; 190 million uniquely mapped reads).
Finally, we carried out mRNA sequencing (mRNA-seq) andobtained 135 million uniquely mapped RNA-seq reads, and
sequenced the corresponding genomic DNA of the two individ-
uals to 303 and 603 coverage.
We began by assessing the distributions of mapped reads
from the libraries obtained by these four independent methods.
As expected (Core et al., 2008; Kwak et al., 2013), GRO-seq
and PRO-seq enriched for sequences near transcription start
sites (TSSs; Figure 1B). This enrichment in mammalian cells is
due to promoter proximal pausing (sense strand) and upstream
divergent transcription (antisense strand) (Core et al., 2008; Seila
et al., 2008). Additionally, the GRO-seq and PRO-seq data pro-
vided sensitive detection of active transcription units and identi-
fied >9,000 transcriptionally active genes. To ensure that we
were looking at very nascent RNAs, we assessed the extent of
splicing in GRO-seq and PRO-seq relative to chromatin-bound
nascent RNA and mRNA. Whereas 20% of the mRNA-seq
reads and 5% of the chromatin-bound nascent transcripts
covered exon-exon junctions, <1% of the GRO-seq and PRO-
seq reads spanned junctions. These nascent transcripts map-
ped throughout transcription units, including introns (Core andCell Reports 6, 906–915, March 13, 2014 ª2014 The Authors 907
Figure 2. Analysis Steps to Identify RDDs
The potential RDD sites were processed in multi-
ple steps with stringent thresholds to confirm their
unique genomic locations. See also Figures S1
and S3, and Tables S1, S2, and S3.Lis, 2008; Core et al., 2008, 2012), whereas mRNA-seq libraries
were dramatically depleted of introns but enriched in the 30 UTRs
due to the sample preparation for polyadenylated transcripts.
These findings support the notion that GRO-seq and PRO-seq
correspond to greatly enriched short nascent RNA that is newly
synthesized (also referred to as ‘‘very nascent RNAs’’ below),
while chromatin-bound RNA represents longer transcripts on
average from a later stage (referred to as ‘‘nascent RNA’’ below).
Figure 1C shows representative results for UVRAG and CAPZB
from sequencing nascent and mature RNAs.
We also compared the expression levels of genes in the very
nascent and mature mRNAs. The very nascent RNA differs
from mature RNA in that the very nascent RNA levels depend
on the density of transcribing Pol II, whereas the mRNA levels
depend on the rate of both transcription andmRNA decay. How-
ever, the levels of transcripts in the two are significantly corre-
lated (r = 0.45, p 0.0001; Figure 1D), with outliers representing
very stable or unstable mRNAs.
RDDs in Very Nascent RNA
Next, we turned to study RDDs in nascent RNA. Defining when
RDDs arise during nascent transcription should help rule out or
support particular mechanisms by which they are generated.
Therefore, we analyzed the RNA sequences and their corre-
sponding DNA sequences to assess how early during transcrip-
tion the RDDs arise. The steps taken to identify RDDs are shown
in Figure 2. At sites that are covered by at least ten uniquelymap-
ped GRO-seq or PRO-seq reads and ten monomorphic DNA
reads (that contain only one nucleotide type [A, C, G, or T]), we
compared the nascent RNA and corresponding DNA sequences,
and identified sites where RNA and DNA sequences are discor-908 Cell Reports 6, 906–915, March 13, 2014 ª2014 The Authorsdant. For a site to be identified as a candi-
date RDD, at least 10% of the GRO-seq
or PRO-seq reads at that site (and a min-
imum of two unique reads) must contain a
sequence that differs from the underlying
DNA sequences. All of the resulting po-
tential RDD sites were further processed
in multiple steps to confirm their unique
genomic locations.
The results uncovered 2,806 RDDs in
one subject (GM12004) and 2,881 RDDs
in the other individual (GM12750; Tables
S1 and S2). The orientation-specific
sequencing allowed us to distinguish all
12 possible types of mismatches be-
tween the DNA and the corresponding
RNA sequences. In this analysis, we
excluded C-to-T RDDs because the
use of 5-bromouridine 50-triphosphate
(BrUTP) in GRO-seq may favor this type of misincorporation
(Yu et al., 1993). All of the 11 remaining types of RDDs were
found, and C-to-G was the most common in both samples (Fig-
ure 3A). We analyzed the PRO-seq data in the same way. Except
for the 30-most nucleotide, the sequenced RNAs from the PRO-
seq sample were made in the cell (as opposed to about half in
GRO-seq), and thus gave us longer segments of in vivo synthe-
sized RNAs for analysis. We found 23,093 RDD sites out of
115 million nucleotides screened, corresponding to one to
two RDD per 10,000 bases screened and a frequency of 2 3
104 RDDs in the PRO-seq sample (Table S3), which is compa-
rable to the frequency of RDD in mRNAs (also 104) (Li et al.,
2011). All 12 types of RDDs were identified (Figure 3B). Even
though both GRO-seq and PRO-seq are global run-on assays
coupled with deep sequencing, they are not identical; therefore,
different numbers of RDDs were detected in the two assays.
Unlike GRO-seq, PRO-seq does not use BrUTP and hence mis-
incorporation that favors C-to-T discordance is not a concern;
therefore, we included all 12 types of RDDs in our analysis.
This added more than 1,700 RDD sites (1,793 C-to-T). In addi-
tion, nearly all of the PRO-seq transcripts (except one or at
most a few bases), as compared with 15–20% of the GRO-
seq transcripts, are made in vivo. Together, the addition of the
C-to-T sites and the longer in vivo synthesized transcripts
allowed us to identify 8-fold more RDD sites in PRO-seq than
in GRO-seq. Despite the differences in number, the distributions
of RDD types are similar between GRO-seq and PRO-seq
samples and across different thresholds of coverage and RDD
levels (Figure S1). This reflects the robustness of our analysis.
To be certain of our results, we confirmed the mapping and the
sequences of the RDD sites in five different experiments and
Figure 3. RDDs in Very Nascent Transcripts
(A and B) Distributions of RDD types in (A) GRO-seq samples of two individuals
and (B) PRO-seq. RDD types are ordered similarly in (A) and (B), except that in
(B), C-to-T RDDs from the PRO-seq sample are included.
See also Figures S2 and S4.
Table 1. Results of Genome Walking Confirm that RDDs Are in
Unique Regions of the Genome
Genomic
Location
RDD
Type
50 Primer 30 Primer
Sequence
No. of
Clones Sequence
No. of
Clones
chr1:152175284 G-to-A G 31 G 9
chr6: 107088915 T-to-A T 19 T 21
chr9:34336911 G-to-A G 14 G 10
chr11:72079055 T-to-C T 10 T 10
chr12:100980077 A-to-C A 11 A 18
chr14:20221257 G-to-T G 14 G 16
chr16: 2140620 A-to-G A 2 A 14
chr19: 2427122 C-to-A C 15 C 1
chr22:42867269 T-to-C T 13 T 14
chrX:7004437 G-to-T G 11 G 10analyses, including genome walking, Sanger sequencing, and
droplet digital PCR (ddPCR) using DNA and RNA from multiple
tissues (Tables 1 and 2; Figure S2; see Supplemental Results
and Discussion for details).
Next, we examined RDDs from different experiments for over-
laps. As one would expect, the overlaps of RDD sites between
the run-on experiments are low, since the ability to resample
an RDD site in independent run-on assays depends on severalparameters, including the density of transcribing Pol II, sequence
depth, and RDD levels. GRO-seq and PRO-seq identify RDD
sites in nascent RNA sequences that are closely associated
(<100 nt) with actively transcribing polymerases. Finding the
same RDD event in two independent samples relies on sampling
an RDD-bearing transcript bound to actively transcribing poly-
merases in both experiments, and the chance of such an occur-
rence is very low. The RDD identification also depends on
sequence depths and the RDD levels (= number of RDD-contain-
ing reads / total number of reads at the site). The median RDD
level among the sites detected in GRO-seq and PRO-seq is
0.24; therefore, high coverage (403) is needed to obtain 80%
of them in replicate samples (Chen, 2013). Nonetheless, 108
RDD sites were found in more than one sample (among the
two GRO-seq and one PRO-seq data sets). The RDD sites we
found in nascent RNAs were also present at a later stage of tran-
scription. In chromatin-bound transcripts where we have longer
transcripts and deeper coverage, we found >1,000 RDD sites
from one of the GRO-seq and/or PRO-seq libraries. The distribu-
tions of these RDD sites are similar to those observed in GRO-
seq and PRO-seq: T-to-G is one of the more abundant types
and A-to-T is less frequent. These results show that the RDDs
in nascent RNAs can be identified by different assays.
RDD Formation Occurs within Seconds after
Transcription
To address how early during transcription RDD events emerge,
we first examined the GRO-seq results. As shown in Figure 1A,
the GRO-seq reads comprise very nascent RNAs that are tran-
scribed in vivo before nuclei isolation occurs and a portion that
are transcribed in vitro during the run-on. Since our very nascent
RNAs are triple selected for BrU incorporation andwe selectively
analyzed reads with an identifiable 30 end of the nascent RNA,
the 30 portion must contain the in vitro transcribed RNA and
the 50 portion must contain some in vivo synthesized RNA. For
both B cell samples, the majority of the RDDs are found in
the 50 portion of the GRO-seq samples, which is enriched for
the in vivo made nascent RNA (Figure 4A). These represent
newly synthesized transcripts that have just exited the activelyCell Reports 6, 906–915, March 13, 2014 ª2014 The Authors 909
Table 2. ddPCR Validation of GRO-seq RDDs
Genomic Location Gene Name RDD Type Feature Individual
Level in Nascent RNA
GRO-seq (%)b ddPCR (%)
1:152175284 DENND4Ba G-to-A coding exon GM12004 20 15
GM12750 0 0
3:197100758 TNK2 G-to-T intron GM12004 0 0
GM12750 9 9
6:161450890 MAP3K4a G-to-T coding exon GM12004 17 1
GM12750 0 2
6:37987903 ZFAND3 G-to-C intron GM12004 0 0
GM12750 7 3
9:34336911 — G-to-A intergenic GM12004 8 19
GM12750 14 27
11:58103493 ZFP91 G-to-C coding exon GM12004 0 0
GM12750 18 10
11:72079055 ARAP1a T-to-C intron GM12004 0 0
GM12750 11 7
12:100980077 — A-to-C intergenic GM12004 18 17
GM12750 0 0
16:69880869 FTSJD1 C-to-G 50 UTR GM12004 9 3
GM12750 0 0
17:30949447 AP2B1 G-to-C coding exon GM12004 0 0
GM12750 10 16
18:8628755 RAB12a T-to-C 30 UTR GM12004 0 0
GM12750 11 9
17:34815068 MED1 G-to-T 30 UTR GM12004 0 0
GM12750 13 10
19:2197783 SF3A2 G-to-C coding exon GM12004 0 0
GM12750 33 10
X:7004437 HDHD1Aa G-to-T intron GM12004 43 50
GM12750 0 0
aAlso found in nuclear RNA fractions of both individuals (Figure S4), except that the site in HDHD1A was found in GM12004 but not GM12750.
bWe included a few RDD sites with levels < 10% in the validations even though the analyses focused on sites with levels > 10%. As shown, even the
sites with lower levels were validated by ddPCR analysis of these same libraries.transcribing polymerase. These findings suggest that RDDs
result from transcription-coupled RNA processing steps.
To further refine the time frame for these RDD events, we used
PRO-seq to localize more precisely the RDD sites relative to
actively transcribing RNA Pol II. In PRO-seq, the in vitro run-on
assay was allowed to proceed for only one or at most a few
nucleotides; thus, the 30 ends of the PRO-seq reads mark pre-
cisely the locations of the transcriptionally active RNA polymer-
ases in our B cells. This offers an opportunity to examine nascent
RNAs that have just exited the active site of Pol II. We examined
where the RDDs were found relative to the actively transcribing
Pol II, and as seen in the GRO-seq data, the RDD events
occurred after the RNA had exited the polymerase (Figure 4B).
Moreover, the increased precision and accuracy afforded by
PRO-seq allowed us to observe the abrupt increase at 55 nt
from the active site of Pol II, corresponding to the sharp increase
in RDD events around position 40 of the PRO-seq reads. As
depicted in Figure 4B, the first 20 bases from the 30 ends of910 Cell Reports 6, 906–915, March 13, 2014 ª2014 The Authorsthe reads are nascent RNAs covered by RNA Pol II; thus, RDD
sites begin to appear35 bases after the RNA exits the polymer-
ase. To confirm this observation, we repeated a PRO-seq exper-
iment. The results confirmed our finding of an increase in RDD at
55 nt from the active site of Pol II (Figure S3A). In contrast, the
RDDs found in mature mRNAs were more uniformly distributed,
as expected (Figure 4C). Moreover, analysis of the sequencing
quality score shows that the increase in RDD around 55 nt is
not a result of a loss of fidelity (Figure S3B). These results are
consistent with those obtained from GRO-seq and demonstrate
that RDD events appear to occur very rapidly (within seconds)
after the nascent RNA is exposed, and do not occur in the
Pol II active site during the catalytic step of synthesizing RNA.
RDD Frequency Is Lower in Cells from a Patient with the
Senataxin Mutation
Our finding that RDDs emerge soon after nascent transcripts exit
from transcription bubbles suggests the coupling of RDDs with
Figure 4. Locations of RDD Sites within
Sequencing Reads
(A) Locations of RDD sites along GRO-seq reads.
Only reads that have defined 30 ends (reads that
contain 30 adaptor sequences) were included in our
analysis.
(B) Locations of RDD sites along PRO-seq reads.
(A and B) Schematic diagrams indicate the loca-
tions of the different segments of GRO-seq (A) and
PRO-seq (B) transcripts along the sequence reads.
(C) Locations of RDD sites alongmRNA-seq reads.
(D) R-loop-forming sequences are enriched in re-
gions immediately adjacent to RDD sites. Average
R-loop scores for 2 kb of regions up and down-
stream of RDD sites are shown. RDD sites have
significantly higher R-loop scores (p < 0.001, t test)
than random control sites.
See also Figures S2 and S3.R loops (White and Hogness, 1977), which also initiate behind
RNA polymerase. We therefore examined this issue and found
that RDDs are enriched significantly (p < 0.001) in regions with
R-loop-forming sequences (Figure 4D; Ginno et al., 2012; Wong-
surawat et al., 2012). To study the co-occurrence of RDDs and R
loops, we carried out PRO-seq using cells from a patient with an
autosomal-dominant form of juvenile ALS (ALS4) due to a muta-
tion (L389S) in the Senataxin (SETX) gene that encodes a DNA/
RNA helicase (Chen et al., 2004). The senataxin protein, SETX,
interacts with RNA Pol II (Chen et al., 2006; Ursic et al., 2004;
Yu¨ce and West, 2013) and plays a role in resolving R loops,
particularly in transcription pause sites (Mischo et al., 2011;
Skourti-Stathaki et al., 2011; Suraweera et al., 2009; Yu¨ce and
West, 2013). The mutation at position 389 corresponds to the
N terminus of SETX, which interacts with other nuclear proteins,
including RNAPol II (Yu¨ce andWest, 2013).We found 50% fewer
RDDs in the very nascent RNA of the ALS4 sample, a frequency
of 9 3 105 compared with 2 3 104 in normal controls.
Compared with controls, the RDD sites in the ALS4 sample
skewed away from G-bearing transcripts: there were signifi-
cantly more (p = 0.03; t test) RDD events that converted G inCell Reports 6, 906–91the DNA (coding/non-template strand)
to other bases in the RNA (32% versus
12% G-to-X, where X = A, C, or T [U]).
Since R loops preferentially form around
nascent RNA that is G-rich (Roy and
Lieber, 2009), this observation suggests
that the fewer RDDs in the ALS4 sample
may be due to less efficient resolution
of R loops. These results encourage
further studies to uncover themechanistic
connection between R loops and RDDs.
A-to-G RDDs in Very Nascent RNA
Are Not Mediated by ADAR
In our B cells, the only known editing
mechanism is ADAR-mediated A-to-G
editing (APOBEC1 is not expressed), so
we asked whether the A-to-G discrep-ancies in the nascent RNAs could be explained by ADAR pro-
teins. Previously, ADAR-mediated editing was found in nascent
RNA of Drosophila (Rodriguez et al., 2012), where nascent
RNAwas defined as chromatin-bound transcripts. We examined
our chromatin-bound transcripts and mature poly-adenylated
RNA, and found A-to-G editing events in both fractions,
consistent with results in Drosophila. However, we did not find
these A-to-G sites in GRO-seq or PRO-seq. For example, from
mRNA-seq, we identified 65 A-to-G sites in POLH, and 48 of
the adenosines were also edited in chromatin-bound RNA; how-
ever, none of these A-to-G sites were detected in the nascent
RNA from GRO-seq or PRO-seq despite good sequence
coverage (Figure S3C). For a more comprehensive analysis, we
turned to results from several recent studies that identified
over 10,000 A-to-G editing sites (Bahn et al., 2012; Carmi
et al., 2011; Kiran and Baranov, 2010; Li et al., 2009; Peng
et al., 2012). None of the RDD sites in GRO-seq overlap with
the editing sites reported in those studies. However, there are
some A-to-G events in nascent RNA from GRO-seq and PRO-
seq, so we compared the features of these A-to-G sites in
nascent RNA with those known to be edited by ADAR-mediated5, March 13, 2014 ª2014 The Authors 911
Table 3. Genes with RDDs in their Nascent RNAs Are Enriched for Roles in Regulation and Metabolism of Macromolecules
GO Term Examples p Value
Gene expression RNF10, ZNF791, KDM2B; DHX9; ELF4 1.8 3 1060
Nucleic acid metabolic process SP3, MAX, RPS6KA4; PSMD11; UTP23 6.2 3 1060
RNA metabolic process RPS24; ELF1; CPEB2; DHX9; NFX1 2.6 3 1058
Cellular macromolecule biosynthetic process DPF1; SEC14L2; RPL18A; UPF1; HARS 4.5 3 1053
Macromolecule biosynthetic process ARFRP1;CTBP2; TSG101; GTF3C2; PARP10 4.3 3 1051
Regulation of macromolecule metabolic process AXIN1; FYN; VCP; SMARCA5; ZNF7 3.9 3 1050
Regulation of cellular metabolic process BCOR; ELL; MTF1; STAT5A; VPS36 2.4 3 1049
Cellular protein metabolic process CCT8; TCF3; RNF115; UBE4B; LNX1 4.9 3 1049
Regulation of primary metabolic process ATG7; CLIP3; YLPM1; CD44; POGK 8.6 3 1047
Regulation of nitrogen compound metabolic process AGRN; SMARCC1; MOV10; SUMO1; HSPA8 4.6 3 1036deamination. We found that the sequence characteristics of the
A-to-G sites in nascent and mature RNAs appear to be different.
Most (>95%) of the ADAR-mediated A-to-G sites in polyade-
nylated mRNAs are found in Alu repeats (Athanasiadis et al.,
2004; Chen, 2013), but in contrast, the A-to-G sites in very
nascent (GRO-seq or PRO-seq) RNAs are not in Alu-containing
regions. In addition, the A-to-G sites in very nascent RNAs do
not have the sequence motif (50 depletion of G [Lehmann and
Bass, 2000]) that flanks ADAR-edited adenosines (Figure S4A;
Wang et al., 2013). These data suggest that there are two distinct
classes of A-to-Gmismatches: those that aremediated by ADAR
and those that occur by a separate mechanism on very nascent
RNA during transcription.
Other Characteristics of RDDs in Very Nascent RNA
Previous studies of RDDs focused on polyadenylated mRNAs
(Bahn et al., 2012; Ju et al., 2011; Li et al., 2011; Peng et al.,
2012). The very nascent RNAs in the present study allowed us
to assess RDDs in regions such as introns that were spliced out
in mature transcripts. Many of the RDDs in very nascent RNAs
are found in intronic regions (28%), which could potentially affect
downstreamRNAprocessing steps. In addition, nearly half (44%)
of the RDDs are intergenic (many of these correspond to gene
isoformswith longer 50 and 30 UTRs relative to the RefSeq forms).
The remaining RDDs (28%) are found in exonic regions and are
evenly divided among coding exons and UTRs (48% and 52%,
respectively). As we found previously (Li et al., 2011), unlike
SNPs, there is no bias against nonsynonymous changes, since
70% of the coding RDD sites lead to alternate amino acids as
predicted by the codon table. We studied the genes that contain
RDD sites in nascent RNA and found that they are significantly
(p < 1030) enriched for roles in regulation and metabolism of
nucleic acids and other macromolecules (see Table 3).
We also examined the sequences (10 bases) surrounding the
RDD sites and found that the sequence context may be impor-
tant. RDDs with the same DNA base share similar sequence
characteristics. In particular, C-to-A and C-to-G, and the
G-to-A, G-to-C, and G-to-T RDDs share similar surrounding
sequences. The RDDs whose DNA base is C reside in regions
that are significantly more C rich, whereas RDDs whose DNA
base is G reside in regions that are significantly more G rich
than negative controls (Figures S4B and S4C; t test, p < 0.05).912 Cell Reports 6, 906–915, March 13, 2014 ª2014 The AuthorsThe enrichments of these nucleotides extend in both the 50 and
30 directions. These regions are more C rich and G rich, but
they are not homopolymer tracts of Cs or Gs (Figure S4D).
Thus, they are different from the cotranscriptional editing of
homopolymer tracts in Ebola (Volchkov et al., 1995) and para-
myxoviruses (Cattaneo et al., 1989; Paterson and Lamb, 1990).
Additionally, RDDs whose DNA base is C show depletion of G
at the base 30 of the RDD, and those whose reference base is
G show depletion of C at the base 50 of the RDD. These features
may affect the DNA and/or RNA structures, or possibly an RNA/
DNA hybrid, which in turn signals for an RDD event asmentioned
above.
DISCUSSION
In this work, we examined where RDDs occur and considered
the results in the context of known RNA-editing mechanisms.
We showed that all 12 types of RDDs are found in RNAs that
have recently extruded from the RNA Pol II exit channel. The
RDD events occurred in vivo on transcripts 35 nt from the
exit channel of Pol II. Pol II elongates in mammalian cells at
20–60 bases per second (Ardehali and Lis, 2009). Therefore,
the RDD events found 35 bases from the exit channel must
occur very shortly after nascent RNA synthesis. Thus, our results
indicate that RDDs are likely to occur within a few seconds of
RNA synthesis and before classic RNA-editing events. RNAs
synthesized by RNA Pol II are quickly modified: 50 caps are
added as the RNA end exits the Pol II RNA channel (Rasmussen
and Lis, 1993), introns are often spliced cotranscriptionally (Car-
rillo Oesterreich et al., 2010; Vargas et al., 2011), and 30 ends are
cleaved and polyadenylated before Pol II terminates transcrip-
tion (Osheim et al., 2002). Based on knowledge about cotran-
scriptional processing events and results from the present study,
we suggest that RDDs occur soon after the capping of the tran-
scripts and before splicing.
Our purpose in examining the timing of RDDs was to narrow
the search for the underlying mechanisms that mediate its for-
mation. A cotranscriptional event that coincides temporally
with RDD formation is the emergence of the R loop (Broccoli
et al., 2000; Drolet et al., 1995; Masse´ and Drolet, 1999). As a
preliminary search for an association between RDDs and the
R loop, we studied RDDs in very nascent RNA of cells from a
juvenile ALS patient with a mutation in the senataxin gene (Chen
et al., 2004). The RNA/DNA helicase senataxin interacts with
RNA polymerase and mediates the resolution of R loops. We
found that the patient had 50% fewer RDDs in her nascent
RNAs. The RDDs seem to be associated with the R loop since
there is enrichment in R-loop-forming sequences (Ginno et al.,
2012) around RDD sites and depletion of G-bearing RDD tran-
scripts in the patient. These findings point to a possible coupling
of RDDs and R-loop formations, and encourage further studies
to uncover the molecular basis.
The GRO-seq and PRO-seq assays allowed us to study very
nascent RNA for RDD formation. However, these methods also
limited our studies to sequences that are covered by or
immediately adjacent (<100 bases) to actively transcribing poly-
merases. It is possible that other mechanisms, such as ADAR-
mediated editing, modify RNA transcripts at a later stage of
RNA processing. Although our results show that RDD formation
occurs very soon after RNA synthesis, they do not imply that all
RDD formations have to occur as early cotranscriptional steps.
Additional methods may be needed to identify or rule out the ex-
istence of other processing steps that modify RNA sequences.
Comparing RNA sequences at different stages of maturity alone
will not provide a comprehensive view because the levels of
many RDD sites are low (<30%), and therefore the depth of
sequencing necessary to conclude that an RDD site is absent
in one stage of transcript synthesis but present in subsequent
stages is difficult to achieve with current sequencing technolo-
gies, given the constraints of error rate and cost. However,
technologies to isolate RNA from different subcellular com-
partments and methods for sequence analysis are rapidly
improving. They soon will allow the tracking of individual tran-
scripts through various processing steps and thus facilitate
the determination of whether there are additional events that
modify RNA sequences. In summary, we have identified
sequence modification as an early RNA-processing step, thus
adding to the already complex set of events that add diversity
to transcriptomes.
EXPERIMENTAL PROCEDURES
Cell Culture
Cultured B cells from two normal individuals in the Centre d’E´tude du Polymor-
phisme Humain database, GM12004 and GM12750, were obtained from
Coriell Cell Repositories. Skin fibroblasts from a forearm biopsy of the juvenile
ALS patient were collected under NIH protocol 00-N-0043, which was
approved by the Intramural Combined Neuroscience Institutional Review
Board of the NIH.
DNA-Seq
DNA-seq libraries were prepared and sequenced on a HiSeq instrument
(Illumina) to obtain 603 and 303 coverage, respectively.
mRNA-Seq and Chromatin-Bound Nascent RNA-Seq
For mRNA sequencing, RNA-seq libraries were prepared according to the
Illumina TruSeq RNA sample preparation protocol. Chromatin-bound nascent
RNA was extracted as previously described (Wuarin and Schibler, 1994). The
mRNA and chromatin RNA were sequenced on a HiSeq instrument.
GRO-Seq and PRO-Seq
Nuclei were isolated from cultured B cells and GRO-seq libraries were pre-
pared with 5 3 106 nuclei as described previously (Core et al., 2008, 2012).PRO-seq libraries were prepared as described previously (Kwak et al.,
2013). Briefly, 5 3 106 nuclei were added to a 23 nuclear run-on reaction
mixture (10 mM Tris-HCl pH 8.0, 300 mM KCl, 1% sarkosyl, 5 mM MgCl2,
1 mM dithiothreitol, 0.375 mM each of biotin-11-A/C/G/UTP [Perkin-Elmer],
0.8 U/ml RNase inhibitor) and incubated for 3 min at 30C. Nascent RNA was
extracted and fragmented by base hydrolysis in 0.2 N NaOH on ice for 10–
12 min, and neutralized by adding a 13 volume of 1 M Tris-HCl pH 6.8. Frag-
mented nascent RNA was purified using streptavidin beads and ligated with
reverse 30 RNA adaptor (50p-GAUCGUCGGACUG-UAGAACUCUGAAC-/
30InvdT/), and biotin-labeled products were enriched by another round of
streptavidin bead binding and extraction. For 50 end repair, the RNA products
were successively treated with tobacco acid pyrophosphatase (Epicenter) and
polynucleotide kinase (NEB). 50 repaired RNA was ligated to reverse 50 RNA
adaptor (50-CUGAACAAGCAGAAGACGGCAUACGA-30) before being further
purified by the third round of streptavidin bead binding and extraction. RNA
was reverse transcribed using 25 pmol of RT primer (50AATGATACGGC
GACCACCGACAGGTTCAGAGTTCTACAGTCCGA-30). The product was
amplified 15 ± 3 cycles and products >150 bp (insert > 70 bp) were PAGE
purified before being analyzed on an Illumina HiSeq 2500 instrument. Two
PRO-seq experiments, one at the Lis lab at Cornell University (Figures 3
and 4) and one at the Cheung lab at the University of Pennsylvania, were
carried out (Figure S3A).
Sequence Analysis
DNA-seq and RNA-seq reads were aligned to the human reference genome
(hg18) using GSNAP (Wu and Nacu, 2010) (version 2012-04-10). A list of
SNP sites in the CEU population from Hapmap (release #28) and 1000
Genomes (pilot project) was used for SNP-tolerant alignments. Alignments
with (read length + 2)/12 – 2 or fewer mismatches were obtained for each
read. PRO-seq sequences were converted to the reverse complements before
alignment. For RNA sequence analysis, known exon-exon junctions (defined
by RefSeq [downloaded March 7, 2011] and Gencode [version 3c]) and novel
junctions (defined by GSNAP) were accepted. Read coverage was analyzed
using RSeQC, and the RPKM (read per kilobase per million reads) for each
gene was calculated (Wang et al., 2012). For GRO-seq and PRO-seq, we
included all of the reads that covered the exon or intron region in computing
the RPKM, but excluded the 1 kb region downstream of TSS, which is overrep-
resented by short transcripts associated with proximally paused Pol II.
RDDs
To identify RDDs, we compared an RNA sequencewith its corresponding DNA
sequence. Low-quality bases (Phred quality score < 20) in both the RNA and
DNA were removed. To be included as RDD sites in the final lists, the following
criteria had to be met: (1) a minimum of ten total DNA-seq reads cover the site;
(2) the DNA sequence at this site is 100% concordant, without any DNA-seq
reads containing alternative alleles; (3) a minimum of ten total RNA-seq reads
cover the site; and (4) the level of RDD (number of RNA-seq reads containing
non-DNA allele / number of all RNA-seq reads covering a given site) isR10%
(aminimum of two RNA-seq reads containing RDD). To ensure the accuracy of
the RDD sites, we performed additional filtering steps using two additional
mapping algorithms. See the Supplemental Experimental Procedures for
further details.
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